People with localised, low-to-intermediate-risk prostate cancer could benefit from Stereotactic Body Radiation Therapy (SBRT), a highly targeted form of radiotherapy, which research suggests may be ...

The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...

New research has found that a rare form of triple-negative breast cancer has a generally favourable long-term prognosis and may not require the same treatment approach as more common triple-negative ...

Christine O’Connell set up the One More City fundraising campaign after she was diagnosed with breast cancer. She and her cycling teammates have raised more than £500,000 to support much-needed ...

Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...

Researchers have demonstrated that a streamlined genetic testing approach could identify more people with inherited breast cancer risk, while reducing the burden on NHS breast and genetic services.

Scientists have uncovered new clues that could help identify which prostate cancers are most likely to become aggressive, according to the first major study to emerge from a landmark international ...

Scientists have provided important evidence that a drug commonly used to treat a type of blood cancer does not appear to reduce patients’ chances of benefiting from later therapies targeting the same ...

Researchers have developed a new method that uses real-world evidence from the NHS Man Van pilot – a community cancer testing service - to identify and specify the requirements needed for new ...